Abstract

Bites by many Asiatic and African cobras (Genus: Naja) cause severe local dermonecrosis and myonecrosis, resulting in permanent disabilities. We studied the time scale in which two Indian polyvalent antivenoms, VINS and Bharat, remain capable of preventing or reversing in vitro myotoxicity induced by common cobra (Naja naja) venom from Sri Lanka using the chick biventer cervicis nerve-muscle preparation. VINS fully prevented while Bharat partially prevented (both in manufacturer recommended concentrations) the myotoxicity induced by Naja naja venom (10 µg/mL) when added to the organ baths before the venom. However, both antivenoms were unable to reverse the myotoxicity when added to organ baths 5 and 20 min post-venom. In contrast, physical removal of the venom from the organ baths by washing the preparation 5 and 20 min after the venom resulted in full and partial prevention of the myotoxicity, respectively, indicating the lag period for irreversible cellular injury. This suggests that, although the antivenoms contain antibodies against cytotoxins of the Sri Lankan Naja naja venom, they are either unable to reach the target sites as efficiently as the cytotoxins, unable to bind efficiently with the toxins at the target sites, or the binding with the toxins simply fails to prevent the toxin-target interactions.

Highlights

  • IntroductionSnake envenoming is a significant public health issue in the tropics [1]

  • Key Contribution: This study investigates the effect of two Indian polyvalent antivenoms in neutralizing local muscle damage by Naja naja venom and concludes that, both antivenoms have antibodies to neutralize Sri Lankan Naja naja venom-induced muscle injury in vitro, such antibodies are unable to reverse the course of the venom-induced muscle damage, which has already begun

  • When addedonprior thevenom-mediated venom in manufacturer-recommended concentrations, VINS anWhen added to themyotoxicity, venom in manufacturer-recommended concentrations, tivenom fullyprior prevented while Bharat antivenom partially preventedVINS

Read more

Summary

Introduction

Snake envenoming is a significant public health issue in the tropics [1]. Literaturebased estimates suggest 0.4–1.8 million envenomings, and 20,000–94,000 deaths occur each year due to snakebites globally [2]. South Asia records the highest snakebite burden in the world, with over two-thirds of the snakebite mortality [2,3]. Most life-threatening effects of snake envenoming are acute, a large number of victims survive with permanent disabilities due to the local necrotic effects of the venom [4]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call